NGNE neurogene.com: Rentabilitas operasi

neurogene.com (NGNE) - logo korporat

Neurogene Inc. (NGNE) minimizes the risk of clinical failures through the variability of its gene therapy programs for neurological pathologies. The operating profit margin clearly demonstrates the financial dynamics, where the current level is approximately 0.00. However, geopolitical tensions complicate the cross-border logistics of biomaterials, while the implementation of robotic laboratories significantly accelerates the screening of therapeutic vectors.

NGNE: Margin dodolan operasi Neurogene Inc 21.02.2024 - 19.11.2026

Rincian analitis perusahaan Neurogene Inc. (NGNE)

- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi saham perusahaan:
Analisis kabeh metrik perusahaan:NGNE, Neurogene Inc.
Barang utama Neurogene Therapeutics

Inelastic demand for genetic brain defect therapies provides Neurogene Inc. (NGNE) with exceptional market influence. Analyzing operational efficiency levels, the investor assesses the ability of the EXACT platform to convert revenue into earnings before interest and taxes. This ratio measures the portion of operating income in every dollar earned. An increase in this metric confirms cost optimization. A stable margin minimizes the asset's default risks.

Perusahaan pesaing

Margin dodolan operasi BIIB|NBIX: Tingkat bathi operasi|Rentabilitas operasi Regencell Bioscience Ltd (RGC)|Margin operasi axsome.com (AXSM)|Margin operasi ACAD (acadia-pharm.com)|XENE - Margin dodolan operasi|vikingtherapeutics.com - Margin operasi|Supernus Pharma (SUPN) - Margin dodolan operasi|CPRX: Margin operasi|Denali Therapeutics Inc. (DNLI) - Margin operasi|Rentabilitas operasi Harmony Pharma|Rentabilitas operasi BHVN|Margin dodolan operasi AMLX (Amylyx Pharmaceuticals, Inc.)|Margin dodolan operasi Trevi Corp TRVI|Rentabilitas operasi praxismedicines.com PRAX|AVXL - Margin dodolan operasi|CeriBell EEG - Margin operasi|Rentabilitas dodolan operasi prothena.com|Alector Therapeutics (ALEC) - Rentabilitas operasi|Annexon Biosciences Inc. - Tingkat bathi operasi|OMER (Omeros Corp) - Margin operasi|ACIU: Tingkat bathi operasi|Margin dodolan operasi VYGR (Voyager Corp)|Margin dodolan operasi Neumora NMRA|Rentabilitas operasi Scilex Holding Company, Inc. SCLX|Tingkat bathi adhedhasar bathi operasi Tevogen Bio Inc.|ACOG - Rentabilitas operasi|Tingkat bathi adhedhasar bathi operasi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Margin dodolan operasi|Cassava Sciences Inc (SAVA) - Margin operasi|Margin dodolan operasi ASRT|Margin operasi coyatherapeutics.com|Margin operasi VTGN|Ovid Therapeutics - Rentabilitas dodolan miturut bathi operasi|Margin operasi ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Margin dodolan operasi|ATHE - Rentabilitas operasi|Rentabilitas kegiatan operasi clene.com CLNN|PEPG: Margin operasi|Rentabilitas dodolan miturut bathi operasi JUNS|RLMD (Relmada Corp) - Margin operasi|Annovis Bio Inc (ANVS) - Rentabilitas kegiatan operasi|Rentabilitas operasi Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Tingkat bathi operasi|Rentabilitas operasi Klotho Neurosciences KLTO|NRSN: Rentabilitas dodolan miturut bathi operasi|RVPH: Margin dodolan operasi|MTVA: Rentabilitas operasi|NRXS (NeurAxis Inc) - Margin dodolan operasi|Margin dodolan operasi Helius Medical Technologies, Inc.|Rentabilitas operasi Passage Bio Inc.|Rentabilitas dodolan operasi bionomics.com.au NEUP|Margin operasi NERV|Margin operasi Athira Pharma Inc (ATHA)|Margin operasi ADXN (Addex Therapeutics Ltd.)|ALZN: Rentabilitas dodolan miturut bathi operasi|CYCN - Rentabilitas operasi|Rentabilitas dodolan operasi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Margin dodolan operasi|Tingkat bathi adhedhasar bathi operasi Cortigent, Inc. CRGT|Rentabilitas operasi Avenue Therapeutics, Inc.|Margin dodolan operasi BrainStorm Cell Therapeutics Inc. (BCLI)|Rentabilitas operasi Cara Therapeutics, Inc (CARA)|Rentabilitas operasi CHRO (Chromocell Therapeutics Corp.)|Margin operasi ELYM (eliemtx.com)|intracellulartherapies.com - Rentabilitas operasi|LBPH: Margin dodolan operasi|Tingkat bathi operasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Margin dodolan operasi|Margin dodolan operasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Margin operasi|Neurotrope - Margin bathi operasi|Margin operasi TRVN|Rentabilitas kegiatan operasi Vigil Neuroscience, Inc.|Rentabilitas operasi Anew Medical, Inc. WENA|CERE - Margin dodolan operasi